- Clinical Trials
- April 2024
- 70 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 160 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- February 2024
- 126 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- October 2023
- 176 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 181 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2022
- 109 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2023
- 79 Pages
Middle East, Africa
From €1365EUR$1,500USD£1,170GBP
- Report
- November 2022
- 226 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- August 2024
- 229 Pages
China
From €3640EUR$4,000USD£3,121GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- July 2023
- 110 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- August 2024
- 93 Pages
China
From €1638EUR$1,800USD£1,404GBP

Itraconazole is an antifungal medication used to treat a variety of fungal infections, including those caused by Aspergillus, Blastomyces, Coccidioides, Histoplasma, and Candida species. It is commonly used to treat infections of the skin, nails, and lungs, as well as systemic fungal infections. Itraconazole is available in both oral and intravenous formulations.
Itraconazole is a key component of the infectious diseases drugs market, as it is used to treat a wide range of fungal infections. It is often used in combination with other antifungal medications, such as fluconazole and amphotericin B, to provide a more comprehensive treatment. Itraconazole is also used to prevent fungal infections in patients who are immunocompromised or have a weakened immune system.
The Itraconazole market is highly competitive, with a number of major pharmaceutical companies offering their own formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more